Completed
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer
NCT03343301
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +8 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
- Marin Cancer Care Greenbrae, California, United States
- Innovative Clinical Research Institute Whittier, California, United States
- The University of Chicago Medical Center Chicago, Illinois, United States